March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Samer Al Hadidi: Longest follow up of phase III clinical trials in myeloma
Mar 17, 2025, 14:20

Samer Al Hadidi: Longest follow up of phase III clinical trials in myeloma

Samer Al HadidiAssistant professor at UAMS Myeloma Center, shared an article on X:

“Longest follow up of phase III clinical trials in myeloma.

  • Median survival >13 years.
  • 41% of patients remained disease free and off therapy with fixed-duration therapy in standard-risk MM.
  • Myeloma is curable for a subset of patients.”

Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma.

Authors: Samer Al Hadidiet al.

Samer Al Hadidi: Longest follow up of phase III clinical trials in myeloma

More posts featuring Samer Al Hadidi.